Inventia

The world’s first high-throughput 3D bioprinting platform designed for cell biology

Brief

Inventia Rastrum’s unique, high-speed 3D printer/bioink system combines specific liquids, cancer cells and human cells in different combinations utilizing a printing technique to form 3D gel spheroids which mimic human tissue.

Rastrum’s ability to accurately print different spheroids consistently, at high speed, enables researchers to run many more experiments to test the ability of certain drug combinations to kill cancer.

Investment

October 2018. Seed. Lead Partner: Mike Nicholls

Co-Investors

Blackbird

Website

Go